Several studies investigating BALF IL-1β levels in patients with COVID-19 have been reported (Nossent et al., 2021; Reynolds et al., 2021; Zaid et al., 2021; Cambier et al., 2022; Voiriot et al., 2022). This evidence concerns the gene IL1B and COVID-19.